Advertisement
Loading...

bioAffinity Technologies, Inc.

BIAFW•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.26
$0.02(10.33%)
U.S. Market opens in 37h 53m

bioAffinity Technologies, Inc. (BIAFW) Stock Overview

Explore bioAffinity Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2M
P/E Ratio-0.54
EPS (TTM)N/A
ROE-3.59%
Fundamental Analysis

AI Price Forecasts

1 Month$0.09
3 Months$0.00
1 Year Target$0.09

BIAFW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of bioAffinity Technologies, Inc. (BIAFW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.54 and a market capitalization of 1.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
10.33%
5-Day Change
-1.93%
1-Month Change
-10.24%
3-Month Change
20.36%
6-Month Change
-0.08%
Year-to-Date (YTD) Change
-24.34%
1-Year Change
104.48%
3-Year Change
-22.12%
5-Year Change
-87.39%
All-Time (Max) Change
-87.39%

Contact Information

http://www.bioaffinitytech.com
+1 210 698 5334
3300 Nacogdoches Road, San Antonio, DE, NaN

Company Facts

57 Employees
IPO DateSep 1, 2022
CountryUS
Actively Trading

Frequently Asked Questions